Overview
- The Purdue University–affiliated startup will develop deep‑learning software to interpret low‑resolution cryo‑EM data for biomolecular structure modeling.
- Daisuke Kihara leads Intellicule, with co‑founders Charles Christoffer and Genki Terashi, and says the tools aim to advance precision‑medicine workflows.
- The software uses state‑of‑the‑art image processing to detect atoms in cryo‑EM maps where conventional methods struggle.
- Intellicule launched in summer 2024 under the name Molecular Intelligence, and received an exclusive commercialization license from Purdue Innovates in January 2025.
- The effort is part of Purdue’s One Health initiative, positioning the technology for translational impact across drug discovery applications.